Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-08-02-2012
Volume36
Issue 8

Pharmaceutical Technology, August 2012 Issue (PDF)

Measuring Growth - Big Pharma's Manufacturing Investments

External Link - article-806905.pdf

Articles in this issue
Pharmaceutical Technology, August 2012 Issue (PDF)
Q&A with Babu Padmanabhan, STEER Engineering
Q&A with Babu Padmanabhan, STEER Engineering
i1-783936-1408600828605.jpg
The Truth About Drug Shortages
Report from Japan
Report from Japan
Pharmaceutical-Based Cargo Security and Theft Prevention
Pharmaceutical-Based Cargo Security and Theft Prevention
Scaling up API Syntheses
Scaling up API Syntheses
Small Changes, System-Wide Impact
Measuring Growth in Big Pharma's Manufacturing Investment
Measuring Growth in Big Pharma's Manufacturing Investment
i3_t-783928-1408600853392.jpg
Gauging Biopharm Outsourcing
i3_t-783935-1408600830960.jpg
In the Spotlight August 2012
i2-783941-1408600815311.gif
FDA User-Fee Legislation Sets Stage for Change
Carbon Measurement Methods for Cleaning Validation (Peer Reviewed)
Carbon Measurement Methods for Cleaning Validation (Peer Reviewed)
Elemental Impurity Analysis
Elemental Impurity Analysis
i1-783939-1408600819925.jpg
Healthcare Reform is Given the Go-Ahead: Now What?
Bioavailability Enhancement: When to Use Hot-Melt Extrusion versus Spray Drying
Bioavailability Enhancement: When to Use Hot-Melt Extrusion versus Spray Drying

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content
Site Logo
August 2nd 2025

Accelerate drug development with innovative 360˚ CDMO and CRO solutions: A comprehensive guide to streamlining drug development and reducing time to market

Patheon
Drug Solutions Podcast: Sustainable Solutions for Biopharma
August 2nd 2025

Drug Solutions Podcast: Sustainable Solutions for Biopharma

Patrick Lavery
In this podcast episode, we discuss sustainable approaches to such equipment and materials as medical propellants, flow sensor technology, and walk-in chambers, plus the critical role of women in elevating and accelerating development in these areas.
Site Logo
August 2nd 2025

Value reimagined: Unlocking ROI and efficiency in drug development

Patheon
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
August 2nd 2025

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Survey with blurred city abstract lights background | Image Credit: © Tierney - stock.adobe.com
August 2nd 2025

Survey: Impacts of Tariffs & Trade Policy on the Bio/pharmaceutical Industry

Christopher Cole
Help us get a better picture of how new tariffs and trade policy have impacted you and your organization.
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 2nd 2025

FDA Changes Opioid Pain Medication Labeling Requirements

Susan Haigney
The changes, required for safety labeling of all opioid drugs, will emphasize the risks with long-term use to combat misuse and addiction.